Biocompatible magnetic fluids of Co-doped iron oxide nanoparticles with tunable magnetic properties by Dutz, Silvio et al.
  
 
TU Ilmenau | Universitätsbibliothek | ilmedia, 2020 
http://www.tu-ilmenau.de/ilmedia 
Dutz, Silvio; Buske, Norbert; Landers, Joachim; Gräfe, Christine; Wende, 
Heiko; Clement, Norbert: 
Biocompatible Magnetic Fluids of Co-doped Iron Oxide Nanoparticles with 
Tunable Magnetic Properties 
 
Original published in: Nanomaterials. - Basel : MDPI. - 10 (2020), 6, art. 1019, 19 pp. 
Original published: 2020-05-27 
ISSN: 2079-4991 
DOI: 10.3390/nano10061019 
[Visited: 2020-06-08] 
 
   
This work is licensed under a Creative Commons Attribution 4.0 
International license. To view a copy of this license, visit  
https://creativecommons.org/licenses/by/4.0/ 
 
  
Nanomaterials 2020, 10, 1019; doi:10.3390/nano10061019 www.mdpi.com/journal/nanomaterials 
Article 
Biocompatible Magnetic Fluids of Co-Doped Iron 
Oxide Nanoparticles with Tunable Magnetic 
Properties 
Silvio Dutz 1,2,*, Norbert Buske 3, Joachim Landers 4, Christine Gräfe 5, Heiko Wende 4 and 
Joachim H. Clement 5 
1 Institute of Biomedical Engineering and Informatics (BMTI), Technische Universität Ilmenau, D-98693 
Ilmenau, Germany 
2 Department of Nano Biophotonics, Leibniz Institute of Photonic Technology (IPHT), D-07745 Jena, 
Germany 
3 MagneticFluids, Köpenicker Landstraße 203, D-12437 Berlin, Germany; ngb.buske@gmail.com 
4 Faculty of Physics and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-
Essen, D-47057 Duisburg, Germany; joachim.landers@uni-due.de (J.L.); heiko.wende@uni-due.de (H.W.) 
5 Department Hematology and Oncology, Jena University Hospital, D-07747 Jena, Germany; 
christine.graefe@med.uni-jena.de (C.G.); joachim.clement@med.uni-jena.de (J.H.C.) 
* Correspondence: silvio.dutz@tu-ilmenau.de; Tel.: +49-3677-691-309 
Received: 29 April 2020; Accepted: 21 May 2020; Published: 27 May 2020 
Abstract: Magnetite (Fe3O4) particles with a diameter around 10 nm have a very low coercivity (Hc) 
and relative remnant magnetization (Mr/Ms), which is unfavorable for magnetic fluid hyperthermia. 
In contrast, cobalt ferrite (CoFe2O4) particles of the same size have a very high Hc and Mr/Ms, which 
is magnetically too hard to obtain suitable specific heating power (SHP) in hyperthermia. For the 
optimization of the magnetic properties, the Fe2+ ions of magnetite were substituted by Co2+ step by 
step, which results in a Co doped iron oxide inverse spinel with an adjustable Fe2+ substitution 
degree in the full range of pure iron oxide up to pure cobalt ferrite. The obtained magnetic 
nanoparticles were characterized regarding their structural and magnetic properties as well as their 
cell toxicity. The pure iron oxide particles showed an average size of 8 nm, which increased up to 
12 nm for the cobalt ferrite. For ferrofluids containing the prepared particles, only a limited 
dependence of Hc and Mr/Ms on the Co content in the particles was found, which confirms a stable 
dispersion of the particles within the ferrofluid. For dry particles, a strong correlation between the 
Co content and the resulting Hc and Mr/Ms was detected. For small substitution degrees, only a 
slight increase in Hc was found for the increasing Co content, whereas for a substitution of more 
than 10% of the Fe atoms by Co, a strong linear increase in Hc and Mr/Ms was obtained. Mössbauer 
spectroscopy revealed predominantly Fe3+ in all samples, while also verifying an ordered magnetic 
structure with a low to moderate surface spin canting. Relative spectral areas of Mössbauer 
subspectra indicated a mainly random distribution of Co2+ ions rather than the more pronounced 
octahedral site-preference of bulk CoFe2O4. Cell vitality studies confirmed no increased toxicity of 
the Co-doped iron oxide nanoparticles compared to the pure iron oxide ones. Magnetic heating 
performance was confirmed to be a function of coercivity as well. The here presented non-toxic 
magnetic nanoparticle system enables the tuning of the magnetic properties of the particles without 
a remarkable change in particles size. The found heating performance is suitable for magnetic 
hyperthermia application. 
Keywords: cobalt ferrite; coercivity; ferrimagnetism; magnetic fluid hyperthermia; magnetic 
nanoparticles; magnetite 
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1. Introduction 
Magnetic nanoparticles (MNPs) and their biocompatible suspensions (ferrofluids) are very 
promising materials for biomedical applications [1,2]. Because of their small size and their high 
surface-to-volume ratio, MNPs show properties which differ from those of the bulk material. Due to 
their magnetic behavior, MNPs enable a mechanical manipulation in an external field or field 
gradient, a magnetic determination of their location, and a heating of the particles by an external 
alternating magnetic field, so that they cannot only be used in therapy, but also in diagnostics and as 
tracer materials. A broad range of applications like in hyperthermia [3,4], in drug targeting [5] or as 
contrast and tracer agent for medical imaging like magnetic resonance imaging (MRI) [6] or magnetic 
particle imaging (MPI) [7,8] of the MNPs are described in the literature. 
A lot of different MNP systems with specific cores and coatings have been developed and tested 
for medical application. Because of their high biocompatibility, iron oxide MNPs are of particular 
interest for application in medicine [9,10]. Due to a good stability against agglomeration and 
sedimentation as well as a high cellular uptake, a lot of research is focused on the application of 
superparamagnetic nanoparticles in the size range of 10–15 nm. 
Unfortunately, such particles are not favorable for aimed hyperthermia heating applications, 
since for maximum hyperthermia heating performance, particles with a slight ferrimagnetism are 
needed [11,12]. An increase in particles size leads to a transition to ferrimagnetism [13] but also an 
increased tendency to form agglomerates. A compromise is the application of so-called multicore 
magnetic nanoparticles (MCNP) with superferrimagnetic behavior, which means ferrimagnetic 
behavior in the presence of an external magnetic field and superparamagnetic behavior in its absence, 
which results in a good stability against agglomeration. These particles are very promising for 
medical applications [14], especially for magnetic fluid hyperthermia because of their high heating 
performance [15,16]. Nevertheless, these cores are in the size range of several 10 nm and exceed the 
here biologically favored size from 10 to 15 nm. 
An approach to achieve ferrimagnetism for small MNPs is the use of cobalt ferrite as magnetic 
core material. Unfortunately, this material shows a very pronounced hard magnetic behavior and for 
particles of about 10 nm, coercivities in the order of 60 kA/m occur [17]. Such coercivities are too high 
to obtain a therapeutically promising heating performance when using a magnetic field strength 
harmless for the patient. Thus, pure cobalt ferrite is not a suitable material for the preparation of 
MNPs in the size from 10 to 15 nm with magnetic properties promising for hyperthermia. 
A possible solution to prepare MNPs in the range of 10–15 nm with a mild ferrimagnetic 
behavior might be Co doping the magnetic iron oxides, expecting a magnetic behavior between those 
of superparamagnetic iron oxide and hard magnetic cobalt ferrite in dependence of the dotation 
degree. In the literature, a non-monotonic dependency of coercivity on Co content for non-
stoichiometric compositions due to magnetically induced anisotropy is described [18]. This was also 
observed for nanoparticles [19] but is not expected for MNPs obtained from the here used preparation 
procedure. The magnetic iron oxide magnetite (Fe3O4=FeO · Fe2O3) as well as the cobalt ferrite 
(CoFe2O4=CoO · Fe2O3) show the crystal lattices of an inverse spinel with a cubic crystal system 
(Fd3m), see Figure 1. The unit cell of the inverse spinel of magnetite Fe2+(Fe3+)2O4 consists of 32 O2− 
ions (O), eight Fe2+ and eight Fe3+ ions on the octahedral sites (Fe–O) as well as eight Fe3+ ions on the 
tetrahedral sites (Fe–T). For cobalt ferrite Co2+(Fe3+)2O4, the tetrahedral sites are occupied again by 
eight Fe3+ ions and the octahedral sites preferably by eight Co2+ and eight Fe3+ ions. This means that 
magnetite and cobalt ferrite have the same crystal lattice but for cobalt ferrite the eight Fe2+ ions on 
the octahedral sites are replaced by eight Co2+ ions, theoretically. Since the lattice constant of 
magnetite (a = 8.3985 Å) is very similar to that of cobalt ferrite (a = 8.3940 Å) and the ionic radii of Fe2+ 
(78 pm) and Co2+ (75 pm) are comparable, it should be possible to replace the Fe2+ step-by-step by 
Co2+ in non-stoichiometric ratios during the preparation, to tune the magnetic properties of the 
obtained MNP. Similar attempts were made before to improve the magnetic properties of tapes for 
magnetic recording [20]. 
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Figure 1. Unit cell of the spinel lattice of magnetite, consisting of 32 O2− ions (O), 8 Fe2+ and 8 Fe3+ ions 
on the octahedral sites (Fe–O) as well as 8 Fe3+ ions on the tetrahedral sites (Fe–T); created with 
CrystalDesigner®. 
For the experimental investigation of this hypothesis, magnetite was prepared by a co-
precipitation process and during the preparation the Fe2+ content of the reagents was replaced by Co2+ 
in different ratios. The obtained MNPs were characterized structurally and magnetically. 
Furthermore, the biocompatibility of the MNPs after citric acid coating was investigated as well as 
their performance for magnetic fluid hyperthermia. 
2. Results and Discussion 
2.1. Structural Properties 
In this study, magnetic nanoparticles (iron oxide/cobalt ferrite) with tunable magnetic properties 
were prepared. To adjust the magnetic properties (mainly the coercivity), during the synthesis of 
magnetite (Fe3O4=FeO · Fe2O3), the Fe2+ ions of magnetite were substituted with Co2+ step by step in a 
stoichiometric range from 0% to 33.3%. Theoretically, a substitution of 0% leads to pure magnetite, 
whereas 33.3% (one third of all Fe atoms are replaced by Co) leads to the formation of hard magnetic 
cobalt ferrite (CoFe2O4=CoO · Fe2O3) and for substitution degrees in between, Co-doped magnetite 
nanoparticles should be obtained. Since the preparation of the particles was performed without an 
exclusion of oxygen, during and after the preparation a proportion of the particle material will turn 
to maghemite (γ-Fe2O3) by further oxidation. For better understanding, the iron oxide particles will 
be rigorously denoted as “magnetite” in this paper. 
The substitution was confirmed by means of inductively coupled plasma optical emission 
spectrometry (ICP–OES). For these measurements it was found that the measured Co content of the 
particle samples was in good accordance with the expected Co content based on the added amount 
of Co2+ ions during the preparation of the particles, see Table 1. ICP–OES determines the total 
proportion of elements within the particles. Thus, for a substitution of 33.3% of the Fe atoms by Co, 
a total amount of 25.1 wt% of Co within the MNPs was theoretically obtained. The results show that 
a defined amount of Co was embedded into the magnetic iron oxide particles. However, these 
measurements provide only information about the amount of Co within the iron oxide. A detailed 
investigation of the crystal lattice is needed to determine the position of the Co2+ within the lattice 
and thus, the resulting magnetic phase, see below in this section. 
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Table 1. Overview on the structural properties of the prepared particles: the Co substitution degree 
(a) during preparation, the expected Co content (theoretically) as well as the measured resulting Co 
content (inductively coupled plasma optical emission spectrometry (ICP–OES)), the diameter from 
TEM (TEM) and XRD (XRD) as well as the hydrodynamic diameter (Dh) from dynamic light scattering 
(DLS); SD = standard deviation. 
           
a Co content  D  Dh 
 theroretic ICP-OES  TEM SD  XRD  DLS SD 
 [%] [%]  [nm] [nm]  [nm]  [nm] [nm] 
           
0.00 0.00 0.0  8.6 ±2.1  7.6  106.2 ±2.1 
0.10 2.51 2.5  8.5 ±2.4  7.5  94.6 ±1.8 
0.25 6.28 6.4  8.6 ±2.0  8.2  102.1 ±2.2 
0.33 8.29 8.6  9.2 ±2.5  8.9  97.8 ±1.9 
0.50 12.56 12.6  9.7 ±2.8  9.0  93.4 ±1.6 
0.75 18.83 19.3  10.9 ±2.9  10.8  106.5 ±2.1 
1.00 25.11 25.1  12.1 ±3.1  12.4  108.3 ±2.2 
           
 
The investigation of the dried ferrofluid samples (citric acid-coated particles dispersed in water) 
by means of transmission electron microscopy (TEM) revealed an overall spherical structure for the 
single particles, a relatively narrow particle size distribution and a low tendency to form 
agglomerates for all particles with different Co contents, see Figure 2. The mean particle size for all 
samples was in the order of 10 nm, see Table 1. For an increasing amount of Co in the particles, a 
slight increase in the particle core diameter was observed. For the magnetite particles (a = 0), a mean 
size of 8.6 nm was determined, which increased to 9.7 nm for a Co content of 12.5% (a = 0.5) until it 
reached 12.1 nm for a Co content of 25% (a = 1). 
 
Figure 2. Typical TEM images of pure magnetite (a = 0) and the particles with a Co content of 12.5% 
(a = 0.5) as well as 25% (a = 1) confirm a slight increase in the particle size for increasing the Co content 
of the particles. The aggregation of the particles occurs during the sample preparation (drying of the 
fluid) for the TEM imaging. 
The investigation of the hydrodynamic diameter of the citric acid-coated magnetic cores 
dispersed in water by means of dynamic light scattering (DLS) revealed for all the samples a 
hydrodynamic diameter of 101.3 ± 6.1 nm. No correlation between the hydrodynamic diameter and 
Co content was observed, see Table 1. This confirmed a weak agglomeration tendency and a good 
stabilization of the cores against sedimentation due to the citric acid coating. 
      
a=0                     a=0.5                  a=1 
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By means of X-ray diffraction (XRD), the phase composition and the particle size was 
investigated. For the plain magnetite (a = 0) and for the cobalt ferrite (a = 1), the found diffraction 
patterns of an inverse spinel with peak patterns typical for magnetite and cobalt ferrite confirmed the 
formation of these magnetic phases. For all substitution degrees between 0 and 1, no remarkable 
changes in the diffractograms were observed, which excludes the formation of impurity phases for 
non-stoichiometric particles, see Figure 3A. For a = 0, the lattice constant was determined to be 8.3537 
Å, which was very close to that of maghemite (8.3515 Å). In combination with a diffraction angle of 
62.85° for the 440-peak of this sample, these results confirmed the magnetic phase to be maghemite 
for the pure iron oxide (a = 0) [21]. When a increases, the lattices constant increases up to 8.3791 Å for 
a = 1, which is in the order of what it is for magnetite (8.3985 Å) and cobalt ferrite (a = 8.3940 Å). 
Unfortunately, XRD did not allow us to distinguish between the magnetite and cobalt ferrite. 
  
Figure 3. (A) X-ray diffractograms of the particles confirm a spinel structure of the particles; for better 
visibility the curves were shifted manually. (B) Particles size derived from XRD and TEM increase 
upon rising Co content. 
By the analysis of the peak broadening of the 440-peak using the Scherrer method, the mean 
particle sizes were derived from the scattering volume of the particles. The here obtained values 
confirm the results from the TEM—an increasing Co content leads to a nearly linear slight increase 
in the particle diameter, see Figure 3B and Table 1. 
From these results it can be concluded that non-stoichiometric Fe2+/Fe3+ ratios during the particle 
preparation did not lead to a solid solution of different magnetic phases but rather to an inverse 
spinel structure with varying ratios of Fe2+ to Co2+ within the crystal lattice, probably on the octahedral 
gaps. This means a linear transition from magnetite to cobalt ferrite when changing the amount of 
Co2+ during the precipitation without remarkable changes in particle size. Since from the XRD data 
solely this hypothesis cannot be proved, a detailed investigation of the lattice structure of the 
particles, their magnetic alignment behavior and Fe-site occupation was performed via Mössbauer 
spectroscopy, see this section below. 
Figure 4A displays the Mössbauer spectra of the CoaFe3-aO4 nanoparticles (a = 0–1) recorded at 
4.3 K. To resolve the individual subspectra of Fe-ions on the tetrahedral A-(blue) and on the 
octahedral B-sites (green), a magnetic field of 5 T was applied along the propagation direction of the 
incident γ-ray. These two observed contributions correspond to Fe3+ on the mentioned lattice sites, 
while for Fe2+ a further spectral component of higher isomeric shift and lower hyperfine magnetic 
field would be expected, which is not visible here [22,23]. In agreement with lattice constants from 
the XRD, this indicates at least the partial oxidation of the relatively small Fe3O4 (a = 0) nanoparticles 
to maghemite (γ-Fe2O3), although minor contents of Fe2+ could be overlooked due to partial 
superposition with the larger B-site Fe3+ component. To reproduce these sextet structures, narrow 
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distributions of effective magnetic fields were used to account for the minor variations in the local 
Fe-surroundings and in spin canting. 
As the subspectral intensities are in good approximation proportional to the number of Fe ions 
on the respective lattice positions, we can obtain information on the Co site occupation by studying 
the ratio of A- to B-site intensity RAB. For a = 0, we obtained RAB ≈ 0.59 ± 0.03, in agreement with the 
assumption of partially oxidized magnetite, as for magnetite twice as much B- than A-site positions 
are occupied by Fe (RAB = 0.5), while in maghemite the ratio increases due to B-site vacancies (RAB = 
0.6). Unlike in magnetite and maghemite, in Co-bearing samples RAB will also reflect the Co-site 
occupation. This is often described in terms of the so-called inversion parameter S [24], which defines 
the occupation of the additional metal ion rather on the tetrahedral A-site in a regular spinel (S ≈ 0) 
or completely on the B-site in an inverse spinel (S = 1), as one would deem more likely due to the B-
site preference of Co2+ [25]. Still, even upon increasing the Co-content, there was no significant 
variation in relative A- to B-site intensity, which would display a preferred B-site occupation. Instead, 
for a higher Co2+ fraction, RAB slightly decreased. For a = 1.0 (CoFe2O4) we observed RAB ≈ 0.53 ± 0.05, 
rather indicating a random placement of Co2+ on both available lattice positions instead of the 
strongly preferred occupation of the octahedral B-site. However, in the context of this study, this can 
be considered as favorable, as the random placement of the Co2+ ions has been repeatedly reported 
to lead to increased saturation magnetization as compared to the inverse spinel structure due to the 
higher uncompensated B-site sublattice magnetization [26,27]. 
 
Figure 4. (A) Mössbauer spectra of the CoaFe3-aO4 nanoparticles recorded at 4.3 K in a magnetic field 
of 5 T applied along the γ-ray incidence direction, composed of Fe3+ ions on the tetrahedral A-(blue) 
and the octahedral B-sites (green). Narrow hyperfine field distributions were used to reproduce the 
individual subspectra. (B) Spin canting angles extracted for the A- and B-site iron and averaged 
canting angles; the line serves as a guide to the eye only. 
In addition to the site occupation probabilities, the Mössbauer spectroscopy provided valuable 
insight into the site-selective orientation of magnetic moments, as the average angle (canting angle 
θ) between the γ-ray—identical here to the direction of the applied magnetic field—and the Fe spins 
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can be determined from the intensity ratio of lines 2 and 3 (respectively 5 to 4) of each spectral 
component following Fermi’s golden rule [28]. B-site canting dominates here as often observed in 
spinel systems, as is expected due to antiferromagnetic B–B superexchange in addition to the superior 
ferrimagnetic structure [29,30]. More surprisingly, Figure 4B displays an increase in θ upon rising Co 
content, with a maximum ca. at a = 0.6–0.8. While on the one hand smaller nanoparticles exhibit an 
increasingly stronger spin frustration due to their higher specific surface, on the other hand the higher 
magnetocrystalline anisotropy of cobalt ferrite as compared to the magnetite often results in stronger 
spin canting in samples comparable in size and crystallinity. Therefore, this observed trend in θ could 
be explained by more pronounced surface spin canting in smaller particles for a ≈ 0 due to their higher 
specific surface [31] and the higher magnetocrystalline anisotropy of CoFe2O4 for a approaching 1.0, 
with both contributions in superposition resulting in a maximum spin frustration at intermediate 
stoichiometries. 
All in all, the Mössbauer spectroscopy indicated primarily Fe3+ ions in the six studied particle 
systems, showing a moderate spin canting and a minor B-site preference of the Co2+ ions. 
2.2. Magnetic Properties 
The quasistatic magnetic properties of the powders of the dried uncoated particles as well as 
ferrofluids of the citric acid-coated magnetic cores were determined by means of vibrating sample 
magnetometry (VSM). 
The saturation magnetization (MS) of the uncoated cores (measured at H = 1275 kA/m) was 
determined to be in the range of 42 to 62 Am2/kg, which represents typical values for nanoparticles 
of magnetite and cobalt ferrite in this size range [32]. An increasing MS for increasing Co content was 
observed, see Figure 5 and Table 2. Since magnetite and cobalt ferrite have a similar bulk saturation 
magnetization of about 80 Am2/kg [33], the transition of magnetite to cobalt ferrite might not be the 
reason for the increasing MS for higher Co contents. Possible reasons for this behavior might be the 
occurrence of maghemite (with a bulk saturation magnetization of about 60 Am2/kg) for lower Co 
content and the experimentally found increasing particles size for higher Co content, see Table 1. 
Thus, for the latter, for a lower Co content, smaller particles with a higher surface-to-volume ratio 
result. Assuming a higher ratio of non-magnetic dead layer on the surface of the particles to the total 
particles volume for smaller particles, smaller particles show a lower net saturation magnetization. 
While Mössbauer spectroscopy indicates higher spin frustration for intermediate to high Co content, 
these findings cannot be directly compared due to different magnetic field amplitude they were 
obtained at. 
 
Figure 5. Saturation magnetization (MS) of powders of bare magnetic particles as function of Co 
content of the partices, measured by means of VSM at H = 1275 kA/m, the line serves as a guide to the 
eye only. 
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Table 2. Overview on the magnetic properties of the prepared particles with varying Co content: the 
saturation magnetization (MS), the coercivity (HC), the relative remanence (MR/MS) as well as the 
specific heating power (SHP) for different magnetic fields strengths during hyperthermia 
experiments at 235 kHz on particles immobilized in gelatine. 
         
        SHP   
a Co MS HC MR/MS  10 20 kA/m 30 kA/m 
 [%] [Am2/kg] [kA/m]   [W/g] [W/g] [W/g] 
         
0.00 0.0 47 0.2 0.00  7 30 33 
0.10 2.5 42 2.1 0.03  16 56 64 
0.25 6.4 50 2.2 0.03  38 125 172 
0.33 8.6 54 3.0 0.04  33 149 231 
0.50 12.6 44 11.9 0.10  8 53 355 
0.75 19.3 62 49.9 0.27  8 37 151 
1.00 25.1 59 84.9 0.42  9 35 72 
         
Figure 6 shows minor loops of hysteresis curves of pure magnetite (a = 0) and particles with a 
Co content of 12.5% (a = 0.5) as well as 25% (a = 1), normalized to the saturation magnetization of 
each curve. It becomes obvious that an increasing Co content led to a more pronounced ferrimagnetic 
behavior (starting from a superparamagnetic behavior for the pure magnetite particles) and the 
coercivity HC varied in a wide range. From Figure 7A,B it can be seen, that for the powder samples, 
a continuous increase in HC took place for the increasing Co content of the particles. This means that 
HC can be tuned in a wide range for this magnetic nanoparticle system by varying the Co content of 
the particles, see Table 2. This is especially true, as seen in Figure 7B, as where HC is plotted on a 
logarithmic scale.It can be seen that even a very small amount (2.5%) of Co within the particles leads 
to a significant increase in HC and a resulting blocked magnetic behavior at room temperature. 
 
Figure 6. Normalized minor loops of pure magnetite (a = 0) and particles with a Co content of 12.5% 
(a = 0.5) as well as 25% (a = 1) recorded at room temperature confirm a significant increase in the 
coercivity for increasing Co content of the particles. The inset depicts a higher magnification of the 
hysteresis curves at low magnetic field strengths. 
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Figure 7. Coercivity of the powder samples (blue spheres) and the fluidic samples (black squares) as 
a function of the Co content, plotted on (A) linear and (B) logarithmic scales; the lines serve as a guide 
to the eye only. 
For the VSM measurements on liquid ferrofluid samples it was found that HC shows only a very 
weak increase for increasing Co content, see the black squares in Figure 7A,B. This confirms the good 
colloidal stability of the fluids without particle agglomerates, as already found by DLS. The slight 
increase in HC for the fluidic samples with increasing Co content might be attributed to the increasing 
particles size for higher Co contents. This size increase led to longer Brown relaxation times [34], 
resulting in a higher HC for the quasistatic measurements of hysteresis curves by means of VSM. The 
relative remanence MR/MS showed a dependency on the Co content similar to that found for the HC 
(see Table 2), as described already before for other particles systems in the transition range from 
superparamagnetic to ferrimagnetic behavior [13]. 
The magnetic heating performance of the particles for hyperthermia application was 
investigated by a magnetic field calorimeter for field strengths of 10, 20 and 30 kA/m for a field 
frequency of 235 kHz. Since in animal investigations it was found that the particles were immobilized 
to the tumor tissue immediately after injection [15], measurements were performed on particles 
immobilized in gelatine. 
In good accordance with the theory [35–37], the specific heating power (SHP) increased with 
increasing field strength in our measurements, see Figure 8. For a lower field strength (10 kA/m), a 
maximum SHP of 38 W/g was obtained for the sample with a HC of 2.2 kA/m (a = 0.25/Co = 6.4%). In 
the medium field (20 kA/m), the maximum SHP is 149 W/g for the sample with a HC of 3.0 kA/m (a = 
0.33 (Co = 8.6%) and for the highest investigated field strength of 30 kA/m, the maximum SHP of 355 
W/g was determined for the sample with a HC of 11.9 kA/m (a = 0.5/Co = 12.6%), see Table 2. 
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Figure 8. SHP of the immobilized particles for three different field strengths (10, 20, and 30 kA/m); 
the lines serve as a guide to the eye only, for some data points error bars are within the symbols. 
This behavior can be explained by the pairing of hysteresis losses of the magnetization curve 
(for a saturation magnetic field strength) and the applied field to reverse the magnetization of the 
particles within the alternating magnetic field generator. As shown before [13], the HC can serve as a 
measure to estimate the hysteresis losses of a particle ensemble. For a certain magnetic field strength, 
the reversal losses increase with increasing HC due to a higher area of the hysteresis curve until the 
losses reach a maximum. Exceeding this maximum, a higher HC led to lower losses, since the 
magnetic field strength was too low to reverse the magnetization of the particle ensemble completely. 
Due to a (possible) particle size distribution, only a fraction of the particles ensemble will show 
reversal losses [11,12] and the effective net losses decrease for a further increasing HC. This means, 
for each applied field strength during hyperthermia, particles with optimum losses (HC) have to be 
chosen to obtain maximum heating. 
For the here presented particle system, the heating performance of the immobilized 
particles was in a range which was suitable for magnetic hyperthermia treatment. The magnetic 
heating performance of the particles could be optimized/adapted for the used magnetic field 
parameters by controlling the Co content (and thus the HC) of the particles. This means that the 
heating performance of the particles can be tuned without a considerable change in particle size. 
2.3. Cell Viability Analysis 
Cell viability analysis enables a statement on the potential cytotoxic effects of the tested MNPs. 
Human brain microvascular endothelial cells (HBMECs) are a prevalent cell line representing the 
human blood–brain barrier [38]. In previous studies we investigated their interactions with MNPs 
where the cells showed a pronounced sensitivity for e.g., polyethylene imine-coated magnetic 
nanoparticles [39,40]. To study the effect of cobalt ferrite MNPs on human cells, HBMEC cultures 
were incubated with MNPs in a range of 5 µg/cm2 –100 µg/cm2 for 24 h (Figure 9). Cell viability testing 
was performed with the PrestoBlue reagent, which was demonstrated to allow a sensitive and robust 
analysis [39,41]. The fluorescence intensity of the reaction product resorufin of the MNP-treated 
samples was related to the untreated control (U). All MNPs independent of cobalt ion content 
exhibited a moderate concentration-dependent effect on HBMECs with at least 71.0% ± 4.1% cell 
viability up to a concentration of 50 µg/cm2. However, the highest MNP concentration (100 µg/cm2 = 
388.8 µg/mL) severely affected the cells and reduced viability to 41.2% ± 6.9% for a = 1. 
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Figure 9. Magnetic nanoparticles (MNPs) with varying Co contents have a minor effect on the cell 
viability up to a concentration of 50 µg/cm2. The PrestoBlue Cell Viability Reagent was added after a 
24 h incubation of the HBMEC samples. Cell-free samples contain 100 µg/cm2 MNPs. The 0.1% (v/v) 
Triton X 100 serves as a toxic control (T). U: untreated HBMEC control; C: cell-free medium control. 
n = 4–8 technical replicates. 
A reason for this observation might be the interference of the MNPs with the PrestoBlue reagent-
based assay. It is reported for several cell viability assays that they might interfere with the 
investigated nanomaterials themselves, with assay components or with reaction products [39,41–44]. 
Therefore, we carried along cell-free controls supplemented with 100 µg/cm2 of MNPs. These samples 
did not exhibit enhanced fluorescence signals compared to the cell-free controls without MNPs (cell-
free medium control = C) (Figure 9). To prove whether MNPs interfered with the PrestoBlue reagent 
product resorufin we measured the cell viability of the untreated cell cultures before and after 
supplementation with 100 µg/cm2 of MNPs. These analyses showed a marked decrease in the 
fluorescence intensity after the addition of MNPs. This pointed clearly to an interaction of the 
fluorescent reaction product resorufin with the MNPs and thus a masking of the fluorescence signal 
(Figure S1). In consequence, the cell viability may be underestimated at least for a MNP concentration 
of 100 µg/cm2 and especially for a = 1. 
Similar drawbacks are reported for the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay which is frequently used to determine the cytotoxicity of nanomaterials, e.g., 
cell lines release the MTT formazane by exocytosis under nanoparticle incubation [45] or some 
nanoparticles absorb fluorescence like carbon black [46]. In general, cell viability evaluation in vitro 
depends on various parameters. The characteristics of the nanomaterial examined including its 
shape, composition and charge have to be considered as well as the concentration applied and the 
duration of the treatment. Furthermore, the in vitro test system like the cell line used or the incubation 
medium composition has to be taken into account. Moreover, the assay characteristics like the 
ingredients and the measuring principle play a role [47]. Therefore, it is advisable to evaluate the 
effects of nanomaterials on cell viability with independent assay systems. 
It has to be emphasized that for the medical application of MNPs, typically a concentration of 
up to 25 µg/cm2 (97.2 µg/mL) was used. In this range, the herein tested MNPs showed only mild 
cytotoxic effects. Comparing for each single concentration the cell viability for different a-values, it 
can be seen that a higher Co content did not lead to increasing cytotoxic effects for concentrations up 
to 50 µg/cm2. Only when the concentration exceeded 50 µg/cm2 a higher Co content lead to stronger 
toxic effects. However, for such concentrations, even the pure iron oxide (a = 0) shows cytotoxicity. 
In order to verify the observed effects of MNPs on cell viability with an independent approach, 
real-time cell analysis (RTCA) was performed. This label-free and impedance-based technique 
monitors the biological condition of cells, e.g., the cell number, viability and the adhesion degree [48]. 
RTCA avoids the interference of MNPs with dyes and allows the monitoring of the dynamic 
responses of the cells in real-time [49,50]. 
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In our experiments, the MNPs were added 24 h after seeding the HBMECs into E16 plates. The 
development of the cell culture under treatment was monitored up to 84 h which means an 
observation period of 60 h. Figure 10 shows the results of RTCA for a = 0 (A), a = 0.5 (B) and a = 1 (C). 
The data were normalized to the time point of the MNP addition (24 h) and denoted as the normalized 
cell index. The untreated control showed a steady increase during the observation period. The 
addition of 25 µg/cm2 of the cobalt ferrite MNPs did not affect the progress of the cell culture. 
Nevertheless, it has to be mentioned that the normalized cell index was below the untreated control. 
Cell cultures incubated with 100 µg/cm2 MNPs showed a tendency towards a reduction of the 
normalized cell index after 60 h of treatment. The MNPs per se had no effect on the measurement 
over the whole period of time (see cell-free samples). Thus, the RTCA supported the idea that cobalt 
ferrite MNPs do not sustainably affect cell viability up to a concentration of 50 µg/cm2. 
 
Figure 10. Real-time cell analysis confirmed no reduced viability of human brain microvascular 
endothelial cells (HBMECs) within 60 h for particles with an increasing Co content in comparison to 
the untreated control (green line); MNPs were added after 24 h which were indicated by the vertical 
dashed line. The basis of the normalized cell index was the 24 h value of the samples, respectively 
(horizontal dashed line). n = 2 technical replicates. 
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The results obtained from the PrestoBlue assay and RTCA were confirmed by vital fluorescent 
staining microscopy. For that, the HBMECs were incubated with 25, 50 and 100 µg/cm2 MNPs for 24 
h. In vital cells, the non-fluorescent calcein AM is converted into green-fluorescent calcein by 
intracellular esterases. Ethidium-homodimer-1 is only able to enter cells when the cell membrane is 
corrupted, thus labelling dead or damaged cells which are prone to die. As demonstrated in Figure 
11, neither iron oxide MNPs (a = 0) nor Co-doped MNPs (a = 0.5 and a = 1) affect the viability of 
HBMEC. Only a few dead cells are detectable. The ratio of these cells is comparable to the untreated 
control. Thus, no elevated toxicity can be observed when the iron oxide MNPs are doped with cobalt 
ions. 
 
Figure 11. Vital fluorescent staining confirmed no reduced cell viability within 24 h for particles with 
an increasing Co content; the living cells and dead cells are colored in green and red, respectively. 
Magnification × 400. 
Co–ferrite MNPs were investigated from several groups for their potential cytotoxicity with 
diverse results [47]. Horev-Azaria and colleagues could demonstrate using several cell lines that Co–
ferrite MNPs exhibited a concentration-, cell-line- and duration-dependent cytotoxic effect [51]. They 
calculated an overall threshold of 200 µM for all cell lines, which was about 13 µg/cm2 in our system. 
Ansari et al. used a modified MTT assay and reported that nanosized cobalt ferrites exhibited only a 
minor toxic effect in a breast cancer cell line up to a concentration of 300 µg/mL [52]. 
Resulting from the cell viability experiments with citric acid-coated MNPs it can be concluded, 
that for concentrations suitable for medical applications, no increased toxicity in our in vitro model 
was observed for increasing the Co content of the MNPs. The cobalt ferrite particles show almost the 
same non-toxic behavior as the iron oxide particles, which are approved for medical application. 
3. Materials and Methods 
3.1. Particle and Ferrofluid Preparation 
The magnetic nanoparticles were prepared by co-precipitation in an alkaline media applying a 
modified protocol of the standard preparation procedure for such particles [53]. For tuning the 
magnetic properties, the Fe2+ ions of magnetite were substituted by Co2+ step by step in our study 
which resulted in a Co-doped inverse spinel lattice with an adjustable Fe2+ substitution degree, see 
Formula (1): 
Nanomaterials 2020, 10, 1019 14 of 19 
 
        (𝐶𝑜 ) + (𝐹𝑒 ) + (𝐹𝑒 ) + (𝑂𝐻 ) →  𝐶𝑜 𝐹𝑒 𝐹𝑒 𝑂 + 4𝐻 𝑂 𝑤𝑖𝑡ℎ 𝑎 = 0 … 1 (1) 
Formula (1). Reaction equation for the preparation of Co-doped inverse spinels. 
A stoichiometric substitution of Fe2+ by Co2+ of 0% (a = 0) leads to the formation of pure magnetite 
particles and at a substitution degree of 33.3% (a = 1), one third of all Fe2+ ions are replaced by Co2+ 
and pure CoFe2O4 results. 
The particles were prepared from Co2+, Fe2+, and Fe3+ chloride mixtures (0.02 molar) at different 
“a” values by co-precipitation with sodium hydroxide under stirring at 100 °C for a 90 min reaction 
time. The obtained particles were washed with distilled water using a magnetic separation technique 
and stabilized in water with hydrochloric acid (intermediate with positively charged particles). 
Subsequently, the particles were coated with citric acid, which resulted in negatively charged MNPs 
at pH7. Finally, the citric acid-coated MNPs were filtrated by a 0.8 µm filter to remove potentially 
existing agglomerates. 
3.2. Structural Characterization 
ICP–OES: The elemental composition of the prepared nanoparticles was determined by means 
of inductively coupled plasma optical emission spectrometry (ICP–OES; Agilent 725 ICP–OES 
Spectrometer, Agilent Technologies). For the ICP–OES measurement, the nanoparticles were 
precipitated and dissolved in aqua regia. 
TEM: For TEM from aqueous solutions, copper grids were rendered hydrophilic by argon 
plasma cleaning for 30 s. Then, 10 µL of the respective sample solution was applied to the grid, and 
excess sample was blotted with a filter paper. TEM images were acquired with a JEM 2010FEF (JEOL, 
Japan). 
XRD: The inner structure of the magnetic nanoparticles was investigated by means of X-ray 
diffraction (XRD, Panalytical X’pert Pro, Malvern Panalytical, Almelo/The Netherlands). The results 
of the XRD investigations provided information about the magnetic phase composition and the mean 
size of the magnetic cores. The size of the cores was calculated from measurements of the XRD line 
width by using the Scherrer formula. The lattice constant was determined by means of Rietveld 
analysis. 
DLS: The hydrodynamic diameters (dh) of the coated cores were determined by using dynamic 
light scattering (DLS, Zetasizer nano ZS, Malvern Instruments, Malvern, UK). Before the 
measurement, samples were diluted in the ratio 1:30 with distilled water and treated in an ultrasonic 
bath. For size measurements, the z-average of the intensity weighted normalization was used. All 
measurements were performed in 3 consecutive runs and the obtained values were averaged. 
Mössbauer spectroscopy: Mössbauer spectra of the nanoparticle samples were recorded in 
transmission geometry and constant acceleration mode with a 57Co(Rh) source. Spectra at 4.3 K were 
measured in a custom-built Thor Cryogenics l-He cryostat containing a setup in split-coil geometry, 
providing a field of 5 T along the incidence direction of the γ-ray. Individual subspectra were 
reproduced by using a narrow distribution of effective magnetic fields for the A- and B-sites using 
the “Pi” program’s Mössbauer fitting routine [54]. 
3.3. Magnetic Characterization 
VSM: The magnetic properties were measured at room temperature by using vibrating sample 
magnetometry (VSM; Micromag 3900, Princeton Measurement Systems, USA). The measurements 
were performed on liquid samples or dried powders. The overall magnetic behavior of the samples 
was derived from magnetization, coercivity and relative remanence measured at H = 1275 kA/m. The 
concentration of MNPs in the fluid was calculated from the obtained saturation magnetization of the 
fluid samples. 
SHP: The specific heating power (SHP) was measured by means of magnetic field calorimetry 
at field amplitudes of 10, 20 and 30 kA/m and at a frequency of 235 kHz as described before [55]. The 
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SHP of the immobilized particles was determined for particles dispersed in a gelatin gel. It was shown 
in previous investigations that this method yields a strong immobilization of the particles. For the 
measurement of the heating curves, the particle suspensions (1 mL in a 2 mL Eppendorf tube) were 
thermally isolated in a PUR foam block and the temperature measurements were performed by a 
fiber optic device (Fotemp, OPTOcon, Dresden, Germany). The MNP concentration of the samples 
for SHP measurements was determined by measuring the specific saturation magnetization using 
the VSM and assuming the specific magnetization values which were obtained from the powder 
samples. 
3.4. Cell Viability Analysis 
Cell culture: The biocompatibility of the prepared samples was studied utilizing human brain 
microvascular endothelial cells (HBMECs). The HBMECs were cultivated at 37 °C and 5% CO2 in 
RPMI 1640 + GlutaMAX™ I (Invitrogen, Karlsruhe, Germany) supplied with 10% (v/v) fetal bovine 
serum (FBS; Biochrom, Berlin, Germany), 100 U/mL penicillin and 0.1 mg/mL streptomycin (Life 
Technologies, Carlsbad, CA, USA). 
PrestoBlue Assay: The cell viability was investigated by using the PrestoBlue Cell Viability 
Reagent (Invitrogen, Karlsruhe, Germany). The assay was based on the reduction of a non-fluorescent 
resazurin-based reagent to fluorescent resorufin by metabolically active cells. First, the cells were 
seeded into black-walled 96-well plates (µ-Clear, F-bottom, Greiner Bio-One, Frickenhausen, 
Germany) and cultivated for 24 h. The subconfluent cell cultures were incubated with particle 
concentrations between 5 and 100 µg/cm2 (which equaled 19.4 to 388.9 µg (MNPs)/mL) in at least 
quadruplicate. These values had a mean total Co concentration from 2.4 to 48.6 µg/mL in the case of 
a = 0.5 and from 4.9 to 97.2 µg/mL in the case of a = 1.0. For the control, sterile water was added 
(untreated control) or the detergent Triton X 100 (0.1%(v/v)). After 24 h of nanoparticle incubation the 
PrestoBlue reagent was added and the incubation was continued for a further 30 min at 37 °C. After 
magnetic separation of the MNP towards the outer walls of the wells and an excitation of the cells 
with light of 550 nm (9 nm bandwidth), a fluorescence signal at 600 nm (20 nm bandwidth) was 
detected by using the microplate reader Infinite M200 Pro (Tecan, Crailsheim, Germany). By 
measuring cell-free wells with added particles, the particle-associated auto fluorescence effect was 
measured and used for the correction of the cell measurements. Similarly, quenching effects were 
considered by fluorescence measurements immediately before and after the addition of particles to 
the cells in the wells. From these investigations, the cell survival rate (which was an indicator for the 
cell toxicity of the particles) was derived for the different particle concentrations at 24 h after the start 
of particle–cell incubation. 
RTCA: The long-term viability of incubated HBMECs was investigated by means of real-time 
cell analysis (RTCA) using the xCELLigence system by ACEA Biosciences (San Diego, CA, USA) as 
described previously [40]. For this, 10,000 cells/cm2 were seeded in each well of a 16 well E plate. The 
cells were monitored in real time at 37 °C in a humidified atmosphere with 5% CO2 after a 
sedimentation waiting step of 30 min. After 24 h cultivation, the particles (25 µg/cm2 and 100 µg/cm2) 
were added to the cells and mixed carefully. RTCA measurements were continued 60 h after adding 
the MNPs. Plain incubation media served as untreated controls. 
Vital fluorescent staining microscopy: The influence of the here prepared MNPs on the viability 
of the cells was examined by determining the ratio of living cells to dead cells using LIVE/DEAD 
viability/cytotoxicity fluorescent staining microscopy as described previously [40]. The HBMECs 
were seeded on glass cover slips (12 mm diameter, Menzel, Braunschweig, Germany) in 24-well tissue 
culture plates (76,000 cells/cm2, Greiner Bio-One). After overnight cultivation, the cell cultures were 
incubated with 25, 50 or 100 µg/cm2 of the MNP for 24 h, respectively. The cells were washed with 
PBS and 100 µL of an ethidium homodimer 1/calcein AM mix (0.3 µM calcein AM and 0.7 µM 
ethidium homodimer 1 in PBS) (Thermo Scientific, Waltham, MA, USA) was added for 3 h. Calcein 
(excitation: 494 nm, emission: 517 nm) and ethidium homodimer-1 (excitation: 528 nm, emission 617 
nm) fluorescence was measured using the confocal laser scanning microscope LSM 510 META (Carl 
Zeiss Microscopy GmbH, Jena, Germany). 
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4. Conclusions 
In the here presented study, magnetic Co-doped iron oxide nanoparticles with tunable magnetic 
properties were prepared. For the Co-doping, Fe2+ ions were replaced by Co2+ in the educts in non-
stoichiometric ratios during the preparation, leading to the formation of pure iron oxide, pure cobalt 
ferrite and non-stoichiometric intermediates between both. The Co content of the obtained particles 
was in good accordance with the Co amount in the educts. The determination of the core size of the 
particles revealed a mean particle size in the range of 8–12 nm with the slight tendency of increasing 
particle sizes for higher Co contents. The measurement of the hydrodynamic diameter of the particles 
after the citric acid coating showed nearly the same behavior for all the investigated particles (Dh ≈ 
100 nm), which confirmed that the particles showed a low agglomeration tendency which was not 
influenced by the Co content. The Mössbauer spectroscopy revealed predominantly Fe3+ in all the 
samples, while also verifying an ordered magnetic structure with low to moderate surface spin 
canting. Relative spectral areas of the Mössbauer subspectra indicated a mainly random distribution 
of Co2+ ions rather than the more pronounced octahedral site-preference of bulk cobalt ferrite. The 
magnetic properties of the obtained particles at room temperature are determined by the Co content. 
An increasing Co content leads to a linear increase in saturation magnetization in the range of 42–62 
Am2/kg. The coercivity and relative remanence increased in a non-linear manner with increasing Co 
content. The higher coercivity for the particles with a higher Co content cannot be explained by the 
larger diameter of those particles but rather by the increasing crystal anisotropy due to the doping. 
A clear correlation between the coercivity and the magnetic heating performance for the different 
magnetic field strengths was found. The SHP values for the most promising particle–field 
combination seem suitable for application in magnetic fluid hyperthermia. By means of cell viability 
analysis utilizing different independent assays and procedures, no cytotoxic effects were observed 
for all prepared coated MNPs (all different Co content cores with citric acid coating) up to 50 µg/cm2. 
It is noteworthy that no increased toxicity was found for the Co-doped particles compared to the pure 
iron oxide ones, which are approved for medical applications. 
In summary, we prepared biocompatible ferrofluids consisting of magnetic nanoparticles 
suitable for application in magnetic hyperthermia. The magnetic properties can be tuned by doping 
with Co in a wide range without a significant influence on the particles size. This enables an adaption 
of the magnetic properties of the used particles to the field parameters of the hyperthermia setup, 
resulting in the optimized heating performance without any change in particles size. In ongoing 
work, we focus on the investigation of the doping range where the transition from 
superparamagnetism to the blocked ferrimagnetic nanoparticle state occurs. 
Supplementary Materials: The following are available online at www.mdpi.com/2079-4991/10/6/1019/s1, Figure 
S1: Co–ferrite MNPs interact with the fluorescent resorufin. 
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